Healthcare provider profile · identity verified

Jesus Montesano, MD

Internal Medicine · HIALEAH, FL · NPI 1295836005

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	327	103
Rosuvastatin Calcium	Rosuvastatin Calcium	309	98
Metformin Hcl	Metformin Hcl	263	75
Amlodipine Besylate	Amlodipine Besylate	254	81
Levothyroxine Sodium	Levothyroxine Sodium	239	67
Losartan Potassium	Losartan Potassium	237	79
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	216	58
Omeprazole	Omeprazole	204	73
Metoprolol Succinate	Metoprolol Succinate	150	51
Clonazepam	Clonazepam	147	27
Alprazolam	Alprazolam	143	32
Vitamin D2	Ergocalciferol (Vitamin D2)	139	54
Tamsulosin Hcl	Tamsulosin Hcl	136	37
Atenolol	Atenolol	130	34
Pantoprazole Sodium	Pantoprazole Sodium	125	44
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	121	62
Famotidine	Famotidine	121	43
Glimepiride	Glimepiride	120	37
Hydrochlorothiazide	Hydrochlorothiazide	118	43
Meloxicam	Meloxicam	117	51
Metoprolol Tartrate	Metoprolol Tartrate	114	35
Clopidogrel	Clopidogrel Bisulfate	104	35
Lisinopril	Lisinopril	103	34
Azithromycin	Azithromycin	102	80
Memantine Hcl	Memantine Hcl	88	28
Quetiapine Fumarate	Quetiapine Fumarate	86	24
Gabapentin	Gabapentin	83	33
Donepezil Hcl	Donepezil Hcl	80	25
Diclofenac Sodium	Diclofenac Sodium	75	31
Dicyclomine Hcl	Dicyclomine Hcl	73	36
Pioglitazone Hcl	Pioglitazone Hcl	71	23
Escitalopram Oxalate	Escitalopram Oxalate	70	22
Pravastatin Sodium	Pravastatin Sodium	68	25
Simvastatin	Simvastatin	65	22
Albuterol Sulfate Hfa	Albuterol Sulfate	64	21
Finasteride	Finasteride	63	18
Fluticasone Propionate	Fluticasone Propionate	61	19
Cefuroxime	Cefuroxime Axetil	58	47
Meclizine Hcl	Meclizine Hcl	57	26
Montelukast Sodium	Montelukast Sodium	57	25
Alendronate Sodium	Alendronate Sodium	56	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	41
Januvia	Sitagliptin Phosphate	49	16
Sertraline Hcl	Sertraline Hcl	46	13
Synthroid	Levothyroxine Sodium	45	11
Clonidine Hcl	Clonidine Hcl	43	14
Furosemide	Furosemide	43	22
Risedronate Sodium	Risedronate Sodium	43	12
Ibuprofen	Ibuprofen	40	17
Temazepam	Temazepam	40	suppressed
Cephalexin	Cephalexin	39	37
Sildenafil Citrate	Sildenafil Citrate	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	18
Diclofenac Sodium Er	Diclofenac Sodium	37	16
Hydrocortisone	Hydrocortisone	37	23
Mupirocin	Mupirocin	37	21
Solifenacin Succinate	Solifenacin Succinate	37	13
Naproxen	Naproxen	36	12
Folic Acid	Folic Acid	35	11
Hydroxyzine Hcl	Hydroxyzine Hcl	35	13
Triamcinolone Acetonide	Triamcinolone Acetonide	35	16
Ozempic	Semaglutide	34	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	33	29
Allopurinol	Allopurinol	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	26
Methylprednisolone	Methylprednisolone	27	24
Latanoprost	Latanoprost	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Ssd	Silver Sulfadiazine	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Eliquis	Apixaban	23	11
Ketoconazole	Ketoconazole	23	suppressed
Pentoxifylline	Pentoxifylline	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Ammonium Lactate	Ammonium Lactate	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	21	suppressed
Dexamethasone	Dexamethasone	21	20
Nifedipine Er	Nifedipine	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Ezetimibe	Ezetimibe	20	12
Lorazepam	Lorazepam	20	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	20	20
Sucralfate	Sucralfate	20	suppressed
Prednisone	Prednisone	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Metronidazole	Metronidazole	18	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Lactulose	Lactulose	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Halobetasol Propionate	Halobetasol Propionate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Primidone	Primidone	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Dupixent Syringe	Dupilumab	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Bystolic	Nebivolol Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Glipizide	Glipizide	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Lamotrigine	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error